Transcriptomics

Dataset Information

0

Expansion of peripheral T cell clonotypes predict response in patients with small cell neuroendocrine bladder and prostate cancers treated with chemo-immunotherapy in a phase I clinical trial


ABSTRACT: To explore the impact of immunotherapy, we report a single institution, dual cohort phase Ib study (NCT 03582475) of platinum-based chemotherapy in combination with PD-1 antagonist pembrolizumab to evaluate safety and preliminary efficacy in patients with small cell bladder and small cell/neuroendocrine prostate cancers. To assess the immunologic basis for responses, single cell gene expression and T cell receptor (TCR) sequencing of serial peripheral blood samples revealed a diverse T cell repertoire with expansion of large clonotypes correlating with response.

ORGANISM(S): Homo sapiens

PROVIDER: GSE266079 | GEO | 2024/10/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-10-11 | GSE273798 | GEO
2024-05-08 | GSE264592 | GEO
2023-02-17 | GSE225078 | GEO
2022-06-20 | GSE188249 | GEO
2022-06-20 | GSE186825 | GEO
2024-01-26 | GSE254250 | GEO
2024-01-22 | GSE253521 | GEO
2023-09-13 | GSE242738 | GEO
2024-07-19 | GSE270050 | GEO
| 2280743 | ecrin-mdr-crc